Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
The report examines the competencies that India has developed in the Pharma & Biotech
industries. It explores how these companies are endeavoring to provide better healthcare
products at better prices through their expertise in pharmacology and biotechnology, and also
provide high quality outsourcing services to international clients.
Issues:
» Understand how the Bitech & Pharma industries are evolving in India
» Learn about the competencies developed by certain companies in both the industries
Contents:
Page No.
Introduction 1
The Evolution of the Industry 2
Biocon India Ltd. 4
Shantha Biotechnics 6
Ranbaxy Laboratories Ltd. 8
Dr. Reddy's Laboratories 10
Looking Ahead 11
Exhibits 12
Keywords:
Innovation, Pharma industry, Biotech industry, Reverse Engineering, TRIPS, Genome Valley,
Biotechnology Enterprise Zones, Bioinformatics, Nicholas Piramal, Value Chain, Shanta
Biotech, Biocon India Ltd., Kiran Mazumdar Shaw, Ranbaxy Laboratories Ltd., Dr. Reddy's
Laboratories
The potential for Indian BioPharma segment is huge. With the implementation of WTO and
patents regime in 2005, Indian companies would not be able to do backward engineering of the
drugs, so they are focusing on in-house R&D. The growth prospects are bright as many contract
research organizations are coming up. Besides, a large number of foreign pharma companies
are setting up their R&D divisions here."
"The trend seems to be that more and more pharma companies are diversifying into the biotech
sector. It would be prudent to have a synergy between the pharma and biotech companies to
avoid cannibalization and killing of effective products."
Introduction
The GoI has more than doubled the biotech research Plan outlay, from Rs 6.22 billion in the
Ninth Plan (1997-2002) to Rs 14.5 billion in the 10th Plan (2002-2007). Apart from funding, the
GoI has eased the regulatory framework by approving genetically modified crops3 and
recombinant-DNA products (rDNA)4; as well as ethical stem cell research5.
One of the parks that was set up was the ICICI Knowledge Park (IKP); this was done in
partnership with ICICI Bank.7 IKP has been leasing out bare and ready-to-use modular
laboratory units each of 3,200 sq.ft. area as well as plots of land for setting up customised R&D
centres.
IKP has also been providing a range of
infrastructure and administrative support services
to create a congenial stress-free environment.
Tamil Nadu was planning to set up biotechnology
enterprise zones to use the bio-resources available
with the state.
IBAB has been conducting courses and training programs in bioinformatics and biotechnology.
It has also been promoting the incubation of new startups in the biotech industry, and conducting
research and development in the field of bioinformatics and other related areas...
Excerpts
The history of biotech industry in India dates back to 1896 when the Plague Research Laboratory was
established by Dr Waldemar Mordecai Haffkine in Mumbai. In 1925, it was renamed the Haffkine
Institute...
Shantha Biotechnics
Shantha Biotechnics (Shantha) was founded by Varaprasad Reddy (Reddy) in 1993. He was the main
promoter together with Yusuf bin Alawi Abdullah, the then Foreign Affairs Minister of Sultanate of
Oman...
Looking Ahead
The consumption of biotech products in India was estimated to be $1.5 billion by 2007 and was likely to
grow to $4.5 billion by 2010. Industry experts believe that the brain drain in these areas may slow down
as India is developing the infrastructure and policies to facilitate the growth of biotechnology...
Exhibits